Dzobo, K.; Hassen, N.; Senthebane, D.A.; Thomford, N.E.; Rowe, A.; Shipanga, H.; Wonkam, A.; Parker, M.I.; Mowla, S.; Dandara, C.
Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe? Molecules 2018, 23, 930.
https://doi.org/10.3390/molecules23040930
AMA Style
Dzobo K, Hassen N, Senthebane DA, Thomford NE, Rowe A, Shipanga H, Wonkam A, Parker MI, Mowla S, Dandara C.
Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe? Molecules. 2018; 23(4):930.
https://doi.org/10.3390/molecules23040930
Chicago/Turabian Style
Dzobo, Kevin, Naseeha Hassen, Dimakatso Alice Senthebane, Nicholas Ekow Thomford, Arielle Rowe, Hendrina Shipanga, Ambroise Wonkam, M. Iqbal Parker, Shaheen Mowla, and Collet Dandara.
2018. "Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?" Molecules 23, no. 4: 930.
https://doi.org/10.3390/molecules23040930
APA Style
Dzobo, K., Hassen, N., Senthebane, D. A., Thomford, N. E., Rowe, A., Shipanga, H., Wonkam, A., Parker, M. I., Mowla, S., & Dandara, C.
(2018). Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe? Molecules, 23(4), 930.
https://doi.org/10.3390/molecules23040930